-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Adjusts Price Target on Boston Scientific to $56 From $50, Maintains Overweight Rating

Morgan Stanley Adjusts Price Target on Boston Scientific to $56 From $50, Maintains Overweight Rating

MT Newswires · 01/06/2023 05:51